Wyatt Langford Leaves Game Due To Quad Tightness, Will Undergo MRI

Rangers outfielder Wyatt Langford left Friday’s 8-7 loss to the Dodgers due to tightness in his right quad.  Langford told reporters (including Shawn McFarland of the Dallas Morning News) that he felt the injury was “pretty minor,” but he’ll undergo an MRI today to explore the quad issue.

Somewhat unusually, the injury occurred when Langford hit a home run in the top of the fifth inning.  Langford said he “reached down” to make contact with Tyler Glasnow‘s pitch, and in the process created some discomfort in his quad that began to surface as he rounded the bases.  Langford remained in left field for the bottom of the fifth, but was replaced by Ezequiel Duran in the bottom of the sixth.  Duran, Sam Haggerty, and Andrew McCutchen could all end up seeing time in left field if Langford ends up on the injured list.

Getting hurt on a homer adds to the snake-bitten nature of Langford’s start to the 2026 season.  Langford’s first home run was just his ninth hit in 53 plate appearances, as the outfielder is batting .170/.185/.340.  His exit velocity and hard-contact numbers are all at least at league average, so a .205 BABIP may be somewhat to blame for Langford’s struggles, though he has also recorded only one walk against 13 strikeouts.

After hitting .247/.335/.423 with 38 homers over his first 1130 PA in the majors, Langford was viewed as a candidate for a true breakout in his third Major League season.  Obviously there’s still plenty of time for Langford to heat up at the plate, though if Friday’s quad tightness lands Langford on the IL, it will mark the fifth IL stint of his young career.  As McFarland notes, the previous four placements were also for soft tissue injuries — a hamstring strain that cost him about three weeks in 2024, and then three separate oblique strains in 2025.

2026-27 Player Option/Opt-Out Preview: April Edition

At the end of each season, certain players will have to decide whether to stick with their current contracts or become free agents. These contract provisions are sometimes referred to as opt-outs and sometimes as player options. Despite the different terminology, they are effectively the same, with the player being the one making the call.

Naturally, the player’s health and performance leading up to the decision will impact which way the player leans. Which players have that decision looming after the 2026 campaign? MLBTR takes a look, in alphabetical order. Player ages in parentheses are for the 2027 season.

The Blue Jays and Berríos agreed to a seven-year, $131MM extension back in November of 2021. The Jays had just acquired Berríos from the Twins a few months earlier, when he had a year and a half of club control remaining. A few months later, with that control window down to one year, they locked him up to keep him around. He could opt out of the final two seasons of the deal, giving him a chance to hit the open market after his age-31 season, when another long-term deal would still be theoretically possible.

Back then, Berríos was a front-of-rotation workhorse who could be banked on for 3-5 WAR per year. He hasn’t been getting as many strikeouts lately, making him feel more like a veteran innings-eater type. From 2022 to 2025, he posted a 4.14 ERA with a 20.7% strikeout rate, 6.9% walk rate and 41.7% ground ball rate.

Even that has been undercut by some injury concerns in recent months. He finished 2025 on the injured list due to elbow inflammation and has started this year on the IL as well, again due to elbow inflammation. The issue doesn’t appear to be major and he could be back with the Jays in the near future. He would have to come back healthy and pitch really well in the next few months for this opt-out to even be a consideration.

  • Bo Bichette (29): can opt out of remaining two years, $84MM, taking a $5MM buyout

Bichette’s recent trip to the open market was an interesting case. He wasn’t the first notable free agent to settle for a short-term deal, but we do know that he could have taken a more traditional long-term pact. The Phillies reportedly offered him a seven-year deal worth around $200MM. That was pretty close to the eight-year, $208MM deal that MLBTR predicted at the beginning of the offseason.

Instead, Bichette went another way. The Mets offered a much higher average annual value on a short-term deal with opt-outs after each season. Bichette can collect $42MM from the Mets for his age-28 season. If he decides to return to free agency, he can take a $5MM buyout on his way out the door, going into his age-29 season.

He would be walking away from a big salary but another $200MM deal might be out there for him if he has another typical Bichette season. Perhaps he would look to lock that in but we have already seen him opt for the bigger salary once. Maybe he would do so again. On the other hand, it’s theoretically possible he can garner better long-term offers this coming offseason. Last time, he had question marks due to his knee injury and uncertain future position. This time, it’s possible he’ll be healthy and have some proof of concept as a third baseman.

Bichette will need to turn things around to even make this a discussion, as he’s off to a .228/.262/.263 start as a Met, but that’s in a small sample size of 61 plate appearances. He has lots of time to heat up.

  • Corbin Burnes (32): can opt out of remaining four years and $140MM ($44MM deferred)

Burnes was a free agent after the 2024 season and few expected him to land in Arizona, but the Diamondbacks signed him to a six-year, $210MM deal, with $64MM deferred. The deal gave Burnes the chance to opt out after two seasons, which would be his age-30 and age-31 seasons.

The deal has not worked out as hoped so far. Burnes did give the club 11 good starts last year, posting a 2.66 ERA, but then required Tommy John surgery in June. He will be on the shelf for at least half of the 2026 season, if not more.

It is theoretically possible for Burnes to beat the remaining money on his deal. Blake Snell was going into his age-32 season in 2025 when the Dodgers gave him a five-year deal worth $182MM. A couple of years prior, Jacob deGrom did better at an even older age. He was going into his age-35 season when he got a five-year, $185MM deal from the Rangers.

For Burnes to make this a conversation, he’ll probably need to come back and shove for at least a few weeks. One or two starts in September won’t do it. It’s also worth considering that Burnes seemingly turned down larger offers from other clubs because he and his family live in Scottsdale. Even if he thinks there’s a chance of slightly more money out there, he might be happy where he is.

  • Kyle Freeland (34) – $17MM player option for 2027 if 170 innings pitched in 2026

Freeland and the Rockies signed a five-year, $64.5MM extension back in April of 2022. The deal runs through 2026 but Freeland can unlock a $17MM player option by getting to 170 innings pitched this year. He hasn’t done that in a while, with 2022 being the last time he hit that mark. Even a minor injury that puts Freeland on the IL for a few weeks would quickly take this off the table.

Presumably, the Rockies don’t want him to trigger this. The deal was signed under the previous front office regime. Even at the time, it was a bit of a head-scratcher. Since it has been signed Freeland’s ERA has mostly been hovering around 5.00. That’s not so bad for a pitcher who plays his home games at Coors Field but the Rockies are now rebuilding and don’t seem likely to be in contention next year.

On the other hand, even without a real eye on contention, they have considered it worthwhile to invest in making the rotation more respectable. After losing 119 games last year, the new front office invested almost $20MM to sign Michael Lorenzen, Jose Quintana and Tomoyuki Sugano. Each of those guys got $8MM or less. Deals like that are probably preferable to spending twice as much on Freeland but it’s not as though that would be back breaking. Freeland is making $16MM this year, so it would be a modest raise.

Helsley became a free agent after last year and a pillow deal seemed likely. He had been so dominant at his best but was coming off a poor platform. From 2022 to 2024, he posted a 1.83 ERA with a 34.6% strikeout rate. But in 2025, his ERA jumped up to 4.50. It was an even worse 7.20 for the Mets, who had acquired him from the Cardinals at the deadline. He only struck out 23.2% of batters faced after the deal. There was some talk that he may have been tipping his pitches, as his stuff seemed the same.

The Orioles gave him a two-year, $28MM deal, with even $14MM salaries in each season. Ideally, Helsley would return to form. That would give the O’s a lock-down closer without a lengthy commitment, while Helsley could return to free agency and get a bigger payday.

The early results are mixed. Helsley has thrown 4 1/3 innings for the O’s. His 30.4% strikeout rate is a nice uptick but he has also walked 17.4% of batters faced in that small sample. He still has lots of time but the sooner he locks in, the more it will help him in the coming offseason.

Holmes spent most of his career as a reliever until he hit free agency, when he drew interest as a starter. The Mets gave him a three-year, $38MM deal and stretched him out. That deal contained an opt-out after two years. That would give Holmes a chance to return to free agency with some proof of concept as a starter, while the Mets would hope to at least get a couple of decent seasons from him.

So far, so good. Holmes is striking out fewer batters as a starter but is still getting plenty of ground balls, leading to good results on the whole. He has thrown 178 1/3 innings as a Met with a 3.38 ERA. His 18.2% strikeout rate is well below his work as a reliever, when he was usually above 25%, but Holmes has induced grounders at a 56.4% clip. He has had a bit of luck from a .273 batting average on balls in play and 75% strand rate, but his 4.09 FIP and 4.39 SIERA suggest he would be a competent back-end starter even with more neutral luck.

A decent starting pitcher can beat $12MM these days, even one in his mid-30s. In the most recent offseason, Nick Martinez got $13MM from the Rays for his age-35 season. Chris Bassitt got $18.5MM from the Orioles for his age-37 season. Merrill Kelly got two years and $40MM from the Diamondbacks starting at age-37. Adrian Houser got two years and $22MM from the Giants beginning with his age-33 campaign, even though he had to settle for a minor league deal a year prior.

Holmes hasn’t been getting as many strikeouts as Kelly or Bassitt but he was comparable to Martinez and Houser last year, with far more grounders than anyone in that group. He’s not an ace but there could be a path to something better than what will be left on his deal.

  • Tatsuya Imai (29) – can opt out of remaining two years, $36MM

Imai is just making his major league debut. Coming from Japan at the end of last season, there seemed to be big divisions in how he was viewed by major league teams. Some saw him as a viable mid-rotation guy but others felt his future would be as a leverage reliever.

Some, including us, thought that a team would bet on the upside. MLBTR predicted Imai to land a six-year deal worth $150MM. It seems no club was willing to go to that length, at least not yet. Imai signed a three-year, $54MM deal with the Astros. Opt-outs after each season give him a chance to return to free agency, ideally with a track record of success as a major league starter. He is still relatively young, turning 28 in May, so he should still be able to secure a long-term deal in the future if the results are there.

It has only been two starts but the numbers have been mixed. Imai has a huge 35.1% strikeout rate but a massive 18.9% walk rate. That lack of control is one of the worries with Imai. He got his walk rate down to 7% in his final NPB season but was above 11% from 2019 to 2023. Beating two years and $36MM would be easy if he’s a 29-year-old mid-rotation starter but he will probably stay if he doesn’t quite cement himself or gets pushed to the bullpen.

  • Michael King (32) – can opt out of remaining two years, $58MM for a $5MM buyout

Not too long ago, King looked to be on his way to a nine-figure deal. He got a rotation chance with the Yankees late in 2023 and made the most of it. The Padres acquired him and put him into their starting group. King responded with an excellent 2024. He kept that going into 2025 until some injury issues popped up. From August 24th of 2023 until May 18th of 2025, King tossed 267 2/3 innings with a 2.72 ERA, 28.4% strikeout rate and 8.1% walk rate. FanGraphs credits him with 6.7 WAR for that span. The only six pitchers ahead of him on that leaderboard are Tarik Skubal, Chris Sale, Zack Wheeler, Logan Webb, Cole Ragans and Dylan Cease.

But King wasn’t able to carry that all the way into free agency. A pinched nerve in his shoulder sent him to the IL for a while. He returned but then quickly went back on the IL with left knee inflammation. He made a few starts in September but wasn’t as dominant as before.

Due to that unimpressive finish, he seemed likely to get a short-term deal with opt-outs, and that indeed came to pass. The Friars brought him back with a three-year deal worth $75MM. It’s a bit backloaded, a team preference since the Padres have been working with some payroll restrictions. King gets a $12MM signing bonus, $4MM annually, but he’ll get all of that even if he opts out. It’s a $5MM salary in the first season and then a $5MM buyout if he walks. Then there’s a $28MM salary in 2027 and $30MM for the final season.

He can easily beat that if he’s back in top form. As mentioned, he was pitching like an ace a year ago and was on a path to something well over $100MM. Even with the injuries, he almost got to nine figures. Through three starts, he has a 3.24 ERA. His 22.1% strikeout rate and 11.8% walk rate aren’t amazing but it’s a very small sample size.

  • Yuki Matsui (31) – can opt out of remaining two years, $13.5MM

After years working as a closer in Japan, Matsui came over to North America ahead of the 2024 season. The Padres signed him to a five-year, $28MM deal. That pact allowed him to opt out after three years, as long as he didn’t have a major injury in the first two.

Matsui stayed healthy and has generally given the Padres solid relief work. He made more than 60 appearances and logged more than 60 innings in both 2024 and 2025. On the whole, he has a 3.86 ERA in 126 innings thus far. However, his 11.3% walk rate is high and his 24.6% strikeout rate is only about two ticks above average for a reliever. He hasn’t really been in a leverage role, with just one save and 12 holds. He began the 2026 season on the IL with a groin strain.

Two years and $13.5MM isn’t a massive amount of money in baseball terms but Matsui won’t beat that if he’s a low-leverage reliever. Those types of guys usually get one-year deals worth a few million. He would have another chance to opt out after 2027.

Pagán’s profile is well known at this point. He gets a lot of strikeouts but also allows lots of home runs. That leads to big swings in his ERA, depending on how many fly balls are leaving the yard. He had a 4.43 ERA with the Twins in 2022, then dropped that to 2.99 in 2023. The Reds signed him to a two-year deal with an opt-out. His ERA spiked to 4.50 in the first season and he decided to stay. He then had a 2.88 ERA in 2025.

He returned to free agency and the Reds re-signed him to basically the same deal as before. The first was $16MM over two years. The second deal gave him a slight bump to $20MM. Pagán has already allowed two home runs through 7 1/3 innings this year, leading to a 6.14 ERA. This one literally depends on which way the winds will be blowing this summer.

Peralta got a four-year, $16.5MM deal from the Padres going into 2024, with the final three seasons all being player options. That was a surprise at the time but the Friars like deals like this, seemingly because of their financial situation. The extra years lower the average annual value and therefore the hit to the competitive balance tax. If the player has a good season and opts out, that’s a loss to the roster but the Padres get him off the books.

With Peralta, he has mostly been a ground ball specialist in his career, getting opponents to pound the ball into the dirt at a 53.8% clip. His 19.1% strikeout rate is below average but he’s still been able to have some good seasons. His first two campaigns in San Diego were fine but weren’t enough for him to trigger either of his first two opt-out chances. He had a 3.99 ERA in 2024 and a 3.14 ERA last year. He has a 3.60 ERA in the early going in 2026.

$4.45MM isn’t a ton of money but veteran relievers can sometimes get squeezed. Andrew Chafin keeps having to settle for minor league deals, for instance. Peralta should probably just stick with San Diego for 2027 unless he has a surprisingly dominant season.

  • Nick Pivetta (34) – can opt out of remaining two years and $32MM

The Padres signed Pivetta to a four-year, $55MM deal ahead of the 2025 season. Due to San Diego’s aforementioned payroll crunch, they backloaded the money. Pivetta got a $3MM signing bonus and $1MM salary in 2025. He is making $19MM this year, followed by two player options worth $14MM and $18MM. The 2027 option becomes a club option if Pivetta misses 130 days for a major injury.

The first season of the deal was the best of Pivetta’s career. He took the ball 31 times and posted a 2.87 ERA, though that may have been a bit fluky. His strikeout and walk rates held fairly steady compared to prior seasons. He went into 2025 with a 15.5% home run to fly ball rate but only 9.7% of his fly balls went over the fence last year. If his home run rates revert back to previous levels, his ERA would likely jump back to his usual range of the low 4.00s.

Two years and $32MM is beatable as a decent 34-year-old. Sonny Gray and Nathan Eovaldi both got three-year deals worth $75MM in recent years. Eovaldi was actually one year older, going into his age-35 campaign. Bassitt got three years and $63MM from the Blue Jays a few years back. Yusei Kikuchi got the same deal from the Angels. As previously mentioned, Kelly got $40MM over two years going into his age-37 season.

Severino signed a three-year, $67MM deal with the Athletics ahead of 2025. The A’s were desperate for pitching. Luring big leaguers there was going to be tough since they were going to be playing in a minor league park from 2025 to 2027. They also needed to spend a bit more to avoid putting their status as a revenue sharing recipient at risk. The Severino deal surpassed expectations and the industry consensus is that the A’s realized they had to overpay someone.

Though Severino accepted that job and has 67 million reasons to feel good about it, he also has a few reasons to feel annoyed and went public with those. It’s possible he’s eager to move on and maybe the opt-out was put into the contract so that he would have the ability to do so.

Last year’s results weren’t amazing, as he posted a 4.54 ERA. The minor league park played as hitter-friendly and may have hurt him, as he had a 6.01 ERA there compared to a 3.02 ERA on the road. However, that road ERA was helped by a tiny .249 BABIP. He only struck out 17% of batters faced in away games, so it’s not as though he was dominating. His 4.34 home FIP and 3.87 road FIP were much closer than the ERA splits.

Unless he really dominates in 2026, sticking with the A’s may be best financial decision. In the most recent offseason, decent starters got less than the $22MM Severino would be turning down. Zac Gallen got $22.025MM but with deferrals that knocked the net present value below $19MM. As mentioned, Houser got $22MM on a two-year deal. Steven Matz got $15MM over two. Bassitt got $18.5MM, Martinez got $13MM and Dustin May got $12.5MM via one-year deals. His 2026 results will play a role but his desire to get out of that minor league park may also be a factor.

Photo courtesy of D. Ross Cameron, Imagn Images

Twins To Place Royce Lewis On Injured List

The Twins will make a couple roster moves before tomorrow’s game at Rogers Centre. Manager Derek Shelton said tonight (relayed by Twins TV’s Audra Martin) that third baseman Royce Lewis and reliever Cody Laweryson are each headed to the injured list. Lewis has a left knee sprain, while Laweryson suffered a right forearm strain. Shelton didn’t specify return timelines for either player.

Lewis suffered his injury during Thursday’s win over Detroit. He came up limping after a swinging strike in his final at-bat of that game. Lewis was able to gut out the plate appearance and hit an infield single. He finished the contest but felt more discomfort today. Bobby Nightengale of The Minnesota Star-Tribune writes that Lewis went for imaging this evening that revealed the sprain.

This will be the ninth injured list stint of Lewis’ four-year MLB career. He has twice torn the ACL in his right knee, once before his big league debut, and battled various left leg injuries. That included a pair of hamstring strains last year. Lewis narrowly topped 100 games for the first time in his career.

The former first overall pick had been out to a nice start. Although he’s only hitting .222, he has taken eight walks and collected four extra-base hits (two doubles and homers apiece). Lewis was at the hot corner for 12 of Minnesota’s first 14 games. Utilityman Tristan Gray has gotten the other two starts and projects as the regular there for the time being. Gray has a homer and a double in the early going but is a .220/.279/.394 hitter over 53 career contests.

Laweryson made his first Opening Day roster this year. The 27-year-old righty made five appearances last season as a September call-up. He has worked 6 1/3 frames of four-run ball (three earned) with eight strikeouts in five outings this year. Laweryson has a save and a hold as part of a wide open Minnesota bullpen.

Minnesota will announce their corresponding call-ups tomorrow. Ryan Kreidler and Eric Wagaman are on the 40-man roster as depth infielders. Kreidler offers more defensive value and is hitting better in Triple-A to begin the season. Zak Kent, who was optioned earlier in the week, seems likeliest to take the bullpen spot if the Twins don’t want to designate anyone for assignment.

Lucas Giolito Throwing Roughly 75 Pitches In Side Sessions

Lucas Giolito is the most notable unsigned player in MLB. The veteran right-hander went unsigned throughout the offseason. There hasn’t been much in the way of public rumors, as reported ties to the Braves and Padres were rather quickly downplayed.

Giolito finished last season with the Red Sox on the injured list due to flexor irritation. That has led some fans to speculate about health as a potential explanation for his remaining unsigned. The free agent starter has maintained he’s fully healthy going back to November, however. He reiterated as much in an appearance on The Baseball Isn’t Boring podcast with WEEI’s Rob Bradford this week, saying he simply hasn’t found what he considers a worthwhile contract offer.

“I just want to play for close to what my value is,” Giolito told Bradford. “Everything is based on these models now. Everyone uses projection and models. My agency (CAA) does the same thing. When you look at models and projections (for value), it’s like ‘alright cool, give me something that’s relatively close to that.’ Let’s go and get it. I’m ready to go.”

The righty said he never felt particularly close to signing over the winter. “The last few months have been very strange. Talks seem like they’re heating up, then it’s like ‘ok never mind,'” he added. The full conversation is worth a listen, as Giolito discusses his free agent process and current training regimen.

He’s working at Cressey Sports Performance in Florida, as he has throughout the winter. He’s throwing around 75 pitches in each of his bullpen sessions. He implied he’s essentially in game shape and wouldn’t need much more of a buildup once he signs. “When I get the opportunity, do you want me to throw a game in Triple-A to get ready or put me right in (the majors) for five innings,” he asked rhetorically. “I’ll do whatever. I’m happy to do whatever once I get the opportunity to help a team.”

That has some parallels to the Blue Jays’ recent signing of Patrick Corbin. The southpaw was reportedly working around 80 pitches in his individual side sessions before Toronto picked him up last Friday. Corbin consented to an optional assignment and made one tuneup start in Low-A. The Jays recalled him today for his team debut. He started and went four innings and 85 pitches in his first MLB appearance.

Giolito could seemingly follow a similar path. It appears to be a financial hangup. Corbin signed a $1MM guarantee, barely north of the league minimum. If Giolito were willing to do that, he’d have been signed months ago. He’s surely not interested in signing for that little after posting a 3.41 ERA across 145 innings for Boston last season.

The former All-Star said he believes that early-season injuries and struggles around the league could increase interest, though he predictably declined to go into detail about which teams might be involved. The Astros, A’s, Angels, Padres and Tigers are among the teams that have had wobbly performances and/or health concerns in the early going.

Speculatively, Houston probably makes the most sense on paper. They’ve started 6-7 despite scoring the most runs in MLB. They’re down their top two starters, Hunter Brown and Cristian Javier, for multiple weeks due to shoulder strains. Tatsuya Imai hasn’t thrown strikes in his first three MLB starts. They’re moving to a six-man rotation despite having Mike Burrows and Lance McCullers Jr. as their two most reliable healthy starters. The Astros are around $12MM below the competitive balance tax threshold.

Padres Place Jeremiah Estrada On Injured List

The Padres placed reliever Jeremiah Estrada on the 15-day injured list minutes before tonight’s game against the Rockies. Jason Adam takes his place in the bullpen, as he has been reinstated from his own IL stint. Estrada is battling elbow tendinitis.

It’s the first roster move of the regular season for the Padres. San Diego’s Opening Day 26-man roster had been unchanged until tonight. They’ll swap out righty setup men at the back of Craig Stammen’s bullpen.

Estrada has been one of the better relievers in MLB over the past couple seasons. He combined for 134 frames of 3.22 ERA ball between 2024-25. Estrada fanned 36.3% of opposing hitters over that stretch, the sixth-best rate among relievers with at least 50 innings. Mason MillerEdwin DíazJosh HaderAroldis Chapman and Devin Williams were the only pitchers who recorded higher strikeout rates. Estrada doesn’t get the same level of fanfare, in part because he hasn’t had many save opportunities, but he tied for fifth in MLB with 30 holds a year ago.

The righty hasn’t been as sharp this year. Estrada has allowed six runs (four earned) on five hits and walks apiece across seven innings. He has recorded eight strikeouts but his swinging strike rate has dropped four percentage points. Estrada’s average fastball has tumbled from 98 mph to 95. He indicated last night that he’d felt fine physically (link via Kevin Acee of The San Diego Union-Tribune). The tendinitis diagnosis buys them some time to see if they can get him right physically and mechanically.

Adam is back from last year’s season-ending quad surgery. The righty suffered a tendon rupture in his left quad at the beginning of September. He’d hoped to make it back for Opening Day. Adam didn’t make his spring debut until a few days before the start of the regular season. The Padres shelved him to begin the year but immediately sent him on a rehab assignment to Triple-A El Paso. He fired five scoreless innings during his ramp-up, albeit with just one strikeout and a diminished 92.9 mph average fastball.

The IL swap delays a tough roster decision in an excellent San Diego bullpen. Ron Marinaccio is their eighth reliever on paper, but he’s out of options. He has tossed 7 2/3 frames of two-run ball to begin the season and would probably get claimed off waivers. Assuming they want to keep Kyle Hart in long relief, they’d either have needed to DFA Marinaccio or option one of David Morgan or Bradgley Rodriguez to create a bullpen spot for Adam.

Broncos’ Ownership Group Purchases Minority Share In Rockies

Penner Sports Group, a company run by the Penner family which owns the NFL’s Denver Broncos, has purchased a minority share in the Rockies. The MLB franchise announced the news this afternoon.

The Rockies specified only that the Penner investment made them the largest minority stakeholder under the Monfort family, which retains majority ownership. Patrick Saunders of The Denver Post provides specifics, reporting that the Penners are purchasing a 40% share of the franchise.

The team didn’t disclose the sale price, though Saunders writes that it’s believed to be around $672MM. The Rockies’ statement said the influx of cash allows them to “retire all outstanding debt while providing additional investment in the team.” It’s unclear if it’ll have any impact on player payrolls in the future. The Penners will remain focused on the Broncos and are not going to have daily responsibilities with the Rockies, Saunders reports.

Most of the major Denver sports franchises, the Broncos included, have been successful in recent years. The Rockies are coming off the first three 100-loss seasons in franchise history. They’ve had seven straight losing campaigns and dropped 119 games last year, tied for third-most in MLB history.

They’ve started this season respectably, going 6-7 while outscoring opponents by six runs, but are unlikely to be even a .500 club for some time. Colorado opened this season with a $117MM payroll, according to The Associated Press, the 21st-highest mark in the league. That’s down marginally from their $122MM season-opening figure in 2025.

Poll: Is Sandy Alcantara Back?

2025 was a season to forget for Marlins righty Sandy Alcantara. The 2022 NL Cy Young award winner looked to be establishing himself as one of the top pitchers in the entire sport just a few years ago, but that reputation has slipped the past few years due to injuries and ineffectiveness. Tommy John surgery Alcantara underwent in late 2023 wiped out his 2024 season. While he returned in time for the start of 2025, he wasn’t an effective starter for most of the year. Overall, he entered 2026 with a 4.73 ERA (95 ERA+) and 4.15 FIP in 59 starts since receiving his aforementioned Cy Young. Those numbers are closer to a fifth starter than an ace and questions over what the righty could really offer a team at this point helped keep him in Miami through last year’s trade deadline and this past winter.

Three starts into his 2026 campaign, Alcantara already seems to be changing the narrative. The righty has posted a sterling 0.74 ERA in 24 1/3 innings of work across his trio of outings this season. Those results are obviously excellent, but Alcantara’s trademark ability to pitch deep into games has been on full display as well; he’s averaged more than eight innings per start so far this year. Neither the sub-1.00 ERA nor his 240-inning pace will continue all year, of course, but what can fans expect from the righty this year?

There are some signals that Alcantara’s hot start to the year might be a mirage. The right-hander has limited his opponents to a .159 BABIP that will be impossible to maintain and sits more than a hundred points below his career norm. He’s also enjoyed a very easy schedule for the start of the season, facing off against bottom-feeders like the Rockies and White Sox while catching the Reds at a time where most of their lineup is scuffling badly. Given that level of competition, it would be understandable to exercise caution regarding the righty until he proves effective against some more challenging offenses.

That’s not to say there isn’t reason for optimism, however. The most obvious one is that Alcantara is now a full year removed from his Tommy John rehab, and his last season where he didn’t deal with elbow troubles or the aftermath of that surgery was his Cy Young 2022 campaign. That’s further supported by the fact that Alcantara improved drastically over the course of the 2025 season. After carrying a ghastly 7.22 ERA into last year’s All-Star break, he posted a 3.33 ERA with a 3.89 FIP the rest of the way, including a 2.62 ERA and 24.9% strikeout rate in the final six weeks of the regular season. When looking at the second half of 2025 in conjunction with the start of the 2026 season, Alcantara looks a whole lot like the ace he once was with a 2.75 ERA, 3.53 FIP, 48.6% ground ball rate, and a 15.5 K-BB% in 108 innings of work across 16 starts.

Zooming back in on his performance so far in 2026, Alcantara’s strikeout and walk rates are better than they’ve been since his Cy Young season and his ground ball rate is trending back up after dropping to just 46.5% last year. The most encouraging sign so far is the complete lack of hard contact Alcantara has allowed. That was the righty’s biggest issue in 2023 and ’25, and while those numbers will take some time to stabilize, things look very encouraging so far in 2026. He’s allowed just one barrel so far this year and his 28.6% hard-hit rate is exceptional thus far. It would be a shock to see those rates stay that low all year, but if he can post a barrel rate in the five to six percent range and a hard-hit rate under 40%, that would leave his profile looking a lot more like it did at his peak than in the years surrounding his surgery, when he combined for a 7.8% barrel rate and a 42.6% hard-hit rate.

How do MLBTR readers think Alcantara’s 2026 season will shake out this year? Will he re-establish himself as one of the league’s top pitchers? If not, will he at least return to being a clearly above-average starter in terms of run prevention for the first time since 2022, or is this hot start merely a flash in the pan? Have your say in the poll below:

What will Sandy Alcantara's 2026 season look like?

Vote to see results

Athletics Place Brent Rooker On Injured List

The Athletics announced today that outfielder/designated hitter Brent Rooker has been placed on the 10-day injured list due to an oblique strain. Infielder/outfielder Zack Gelof has been recalled as the corresponding move.

It’s not an especially surprising development. Rooker appeared to injure himself on a swing yesterday, reaching for his side. He was removed from the game with the A’s announcing his issue as right flank discomfort. Gelof was scratched from the Triple-A lineup, which suggested he would likely be called up to take Rooker’s place.

The A’s haven’t announced how long they expect Rooker to be out but obliques can be pesky injuries for baseball players since they play a notable role in rotating the body, which is important for swinging and pitching. Rooker is out to a slow start this year, with a .146/.245/.293 line, but in a small sample of 49 plate appearances. In a much larger sample of 1,839 plate appearances from 2023 to 2025, he hit 99 home runs and slashed .268/.343/.509.

The one benefit for the A’s is greater positional flexibility, as Rooker is usually the designated hitter. They can now use that spot to move guys in and out, lightening their workloads from time to time. Gelof has only played second base in his big league career but has been dabbling with some outfield work lately. The A’s have mostly been using Jeff McNeil at second. He’s the oldest regular position player, so perhaps he will get some more time as the DH.

Gelof has shown power in his big league career but has also been punched out in a third of his plate appearances. He’ll need to get that down to become a viable big leaguer. For what it’s worth, his minor league season has started well. He has only been punched out at a 13% clip in his small sample of 54 trips to the plate, which has helped him produce a monster .366/.519/.732 line. No one should expect him to hit like that in the majors but any improvement in the strikeout department should be a big help.

If the A’s want to try him in the outfield, their current mix includes Tyler Soderstrom, Denzel Clarke, Lawrence Butler and Carlos Cortes. Using Rooker’s vacated DH spot could allow the club to potentially spread some at-bats to that group and Gelof.

Photo courtesy of Wendell Cruz, Imagn Images

Astros Select J.P. France, Taylor Trammell

April 10th: The Astros announced the expected moves today. Trammell and France have been added, with Blanco transferred to the 60-day IL. Javier’s injury was listed as a grate two shoulder strain and Meyers’ is a grade two oblique strain. Both are retroactive to April 9th.

April 9th, 11:13 am: Brian McTaggart of MLB.com reports that the Astros are also planning to select outfielder Taylor Trammell. This almost certainly indicates that fellow outfielder Jake Meyers is headed to the injured list. Meyers exited on Wednesday with lower back tightness. Like France, Trammell will require a spot on the 40-man roster, and currently, Houston only has one opening. That means the Astros will have to free up one more space to add both France and Trammell before tomorrow’s game. Ronel Blanco, who is recovering from Tommy John surgery last June, is a likely candidate to move from the 15-day IL to the 60-day IL.

Trammell, 28, is a five-year MLB veteran. After bouncing from the Mariners to the Dodgers to the Yankees in 2024, he was traded to the Astros ahead of the 2025 campaign. A pair of IL stints limited him to 52 games for Houston, though that was still a career-high for the lefty batter. He slashed .197/.296/.333 with an 80 wRC+, mostly splitting his time between left and center field. He was DFA’d and sent outright to Triple-A after the season. However, a hot spring (.904 OPS, 136 wRC+) and an even hotter start for Sugar Land (1.003 OPS, 177 wRC+) have earned him another chance in the majors. He’s likely to serve as at least the strong half of a platoon in center field while Meyers is on the shelf.

10:00 am: The Astros will select J.P. France’s contract from Triple-A Sugar Land before tomorrow’s game against the Mariners, reports Chandler Rome of The Athletic. He will be able to take the 40-man roster spot left vacant after Roddery Muñoz was designated for assignment on Monday.

As for the 26-man roster, there’s a good chance France is replacing Cristian Javier, who exited his start on Wednesday with shoulder tightness. It’s also possible the Astros won’t be ready to make a decision about Javier by tomorrow, but that they still want a fresh arm for the bullpen, given the workload their relievers shouldered in yesterday’s 9-1 loss. In that case, they might consider optioning AJ Blubaugh, who has given up nine runs on nine hits in his last two outings. Meanwhile, Spencer Arrighetti is the most likely candidate for a call-up if Houston needs a longer-term replacement for Javier in the rotation. Jason Alexander is also available at Triple-A.

France, 31, made 23 starts for the Astros in 2023, his rookie campaign. Unfortunately, a shoulder injury ruined his next two seasons. He made just seven appearances for Houston between 2024 and ’25 and struggled in a handful of minor league outings as well. The team designated him for assignment this past offseason and sent him outright to Triple-A. However, if the early results from 2026 are any indication, France seems to be throwing with a healthy shoulder again. He struck out 13 batters in 11.2 innings this spring and another eight in his first 5.1 frames for the Sugar Land Space Cowboys. The righty has yet to allow a run at Triple-A, with just one walk and two hits allowed to the 19 batters he’s faced.

If France can get back to pitching the way he did in 2023 – whether he’s starting or working in long relief – the Astros will surely be grateful. Through 13 games, Houston’s pitchers have the highest ERA in the AL (6.05). Walks and home runs have both been serious problems. What’s more, two of the team’s most important arms are on the injured list: Hunter Brown (shoulder strain) and Josh Hader (biceps tendinitis). Losing Javier for any period of time would only further weaken a beleaguered staff. While the team still has depth arms to call on for the rotation and the bullpen, those options are starting to wear thin.

Brewers Sign Reiss Knehr to Minor League Deal

The Brewers signed right-handed pitcher Reiss Knehr to a minor league deal yesterday, according to his transactions tracker at MLB.com. He has been assigned to the Arizona Complex League (ACL) Brewers squad, likely in an effort to build up following an injury-shortened (yet still effective) showing at Triple-A El Paso in 2025. He would presumably fill out the upper minors of Milwaukee’s system as an emergency starter or long-relief depth option. Knehr is represented by ACES.

Knehr, a former 20th-round pick by the San Diego Padres, has seen only limited major league action. Across three seasons (2021-2023) for the big league club, Knehr appeared in 21 games and tossed 48 1/3-innings, primarily out of the bullpen. However, he did make seven starts; he could serve in a similar spot starter/opener role for the Brewers in the event of injuries to the Major League staff.

His 5.96 ERA is unsightly. MLB batters facing Knehr struck out at only a 15.5% clip, walked at an elevated 13.2% rate, and put the ball on the ground only 32.0% of the time (all well below-average metrics for an MLB pitcher). Knehr’s career 5.75 SIERA, a backwards-looking ERA estimator, is only slightly below his career ERA, suggesting his results are not due to misfortune or the flukiness of a small sample size.

Unfortunately, Tommy John surgery ended Knehr’s 2023 season prematurely and wiped out his 2024. He returned on a minor league deal with San Diego during the 2024 offseason and generated velocity improvements to his fastball (+1.2 MPH), cutter (+1.4 MPH),  and sinker (+2.0 MPH), resulting in a career-high 36.9% K% in 16.2 Triple-A innings, but did not receive a call-up to the big league club. He spent the latter parts of the season on the minor league injured list, not making an appearance after May 21st.

After electing free agency at the end of the 2025 season, Knehr will continue his MLB comeback with an organization that has a knack for pitching development. And while Knehr is far from a sure thing for the Brewers, he represents a risk-free minor league signing. If he makes the team, he is out of options but can be retained for five years should he make an impact on the major league roster.